Education
About Us
Working with TipRanks
Follow Us
Biogen (BIIB)
NASDAQ:BIIB
Earnings Data
Report Date
Jan 29, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
2.16Last Year’s EPS
3.44Same Quarter Last Year
Moderate Buy
Based on 24 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Biogen's earnings call reflected a strong performance in new product launches and pipeline progress, with significant revenue growth in key segments offsetting some challenges, particularly in Europe and China. The financial results and strategic focus on pipeline expansion suggest a positive outlook.Company Guidance
Strong Revenue Growth in Launch Products
Biogen's launch products demonstrated a year-on-year growth of 67% in Q3 2025, significantly offsetting the decline in MS revenue.
LEQEMBI Sales and Global Demand
LEQEMBI continues to show strong global demand with Q3 sales of $121 million and positive feedback from customers and payers.
Pipeline Progress
Litifilimab Phase III studies in SLE are fully enrolled with expected readouts in 2026, indicating strong commercial potential.
ZURZUVAE Revenue Growth
ZURZUVAE saw a 19% revenue growth compared to the previous quarter, driven by increased demand and new prescribers.
Financial Performance
Biogen delivered a 3% revenue growth overall, with non-GAAP diluted EPS growth of 18% and $1.2 billion in free cash flow in Q3 2025.
BIIB Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BIIB Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | $147.86 | $149.61 | +1.18% |
Jul 31, 2025 | $126.64 | $128.00 | +1.07% |
May 01, 2025 | $121.08 | $120.93 | -0.12% |
Feb 12, 2025 | $139.39 | $133.43 | -4.28% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Biogen (BIIB) report earnings?
Biogen (BIIB) is schdueled to report earning on Jan 29, 2026, Before Open (Confirmed).
What is Biogen (BIIB) earnings time?
Biogen (BIIB) earnings time is at Jan 29, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BIIB EPS forecast?
BIIB EPS forecast for the fiscal quarter 2025 (Q4) is 2.16.
